8.6 Online Preliminary
SureMed provides pharmaceuticals, healthcare providers and patients the highest quality, and reliable and effective platforms for digitally tracking usage of parenteral drugs using its ePlungers, eCaps and eSleeves, etc in high quality and low cost.
SureMed’s competency is in its disruptive technologies and quality management.
autologous transplantation for tissue and organ regeneration.
Our development programs are primarily focused Myocardial Ischemia, reperfusion injury and neurodegenerative & neuromuscular diseases including: Huntington’s Disease, Multiple Sclerosis/Optic Neuritis, Wolfram Syndrome, Epilepsy, Traumatic Brain Injury (TBI), Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, and Parkinson Disease. On-going research has linked these diseases to various malfunctions of the mitochondria. MDX LIFESCIENCES, Inc. aims at opening the way for a broad range of disease modifying therapies for tissue regeneration and achieving clear clinical end points to monitor the various therapies.
PhysioCue, Inc. is a four-year-old consumer digital health and therapy device development company located in the heart of Silicon Valley. PhysioCue devices empower people with high blood pressure to live healthier, happier and longer lives.
We have developed an innovative, non-invasive approach to thermo-neuro-stimulation of the nervous system for immediate and sustainable hypertension reduction therapy management that includes our patented BP Bio-sensor (PPG & ECG) technology.
ZhuHai Institute of Advanced Technology Chinese Academy of Science
Renvigor Biosciences Co.
Top10 Entrepreneurship Tutors of Zhejiang Province
Beijing Huiyu Biomedical Technologies LLC